Amithiozone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Amithiozone
Accession Number
DB12829
Description

Amithiozone has been used in trials studying the treatment of Mycobacterium Avium-intracellulare Infection.

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 236.29
Monoisotopic: 236.073182196
Chemical Formula
C10H12N4OS
Synonyms
  • Amithiozone
  • Thioacetazone
  • Thioacétazone
  • Thioacetazonum
  • Tioacetazona
External IDs
  • NSC-3550
  • RP 4207
  • SDT 1041
  • SQ-2321
  • TB I-698

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcenocoumarolThe risk or severity of bleeding can be increased when Amithiozone is combined with Acenocoumarol.
DicoumarolThe risk or severity of bleeding can be increased when Amithiozone is combined with Dicoumarol.
FluindioneThe risk or severity of bleeding can be increased when Amithiozone is combined with Fluindione.
LactuloseThe therapeutic efficacy of Lactulose can be decreased when used in combination with Amithiozone.
MagnesiumThe serum concentration of Magnesium can be decreased when it is combined with Amithiozone.
PhenindioneThe risk or severity of bleeding can be increased when Amithiozone is combined with Phenindione.
PhenprocoumonThe risk or severity of bleeding can be increased when Amithiozone is combined with Phenprocoumon.
Picosulfuric acidThe therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Amithiozone.
Typhoid vaccineThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Amithiozone.
Vibrio cholerae CVD 103-HgR strain live antigenThe therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amithiozone.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Categories

ATC Codes
J04AM04 — Thioacetazone and isoniazidJ04AK07 — Thioacetazone
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as acetanilides. These are organic compounds containing an acetamide group conjugated to a phenyl group.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Anilides
Direct Parent
Acetanilides
Alternative Parents
N-acetylarylamines / Thiosemicarbazones / Acetamides / Secondary carboxylic acid amides / Organosulfur compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Acetamide / Acetanilide / Aromatic homomonocyclic compound / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Hydrocarbon derivative / N-acetylarylamine / N-arylamide / Organic nitrogen compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
MMG78X7SSR
CAS number
104-06-3
InChI Key
SRVJKTDHMYAMHA-WUXMJOGZSA-N
InChI
InChI=1S/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+
IUPAC Name
N-{4-[(E)-[(carbamothioylamino)imino]methyl]phenyl}acetamide
SMILES
CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1

References

General References
Not Available
PubChem Compound
9568512
PubChem Substance
347828995
ChemSpider
7843221
ChEMBL
CHEMBL375492
ZINC
ZINC000017970372
Wikipedia
Thioacetazone

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentInfection, Mycobacterium Avium-Intracellulare1
Not AvailableRecruitingNot AvailableTuberculosis (TB)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0505 mg/mLALOGPS
logP1.75ALOGPS
logP0.9ChemAxon
logS-3.7ALOGPS
pKa (Strongest Acidic)11.71ChemAxon
pKa (Strongest Basic)2.49ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area79.51 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity69.1 m3·mol-1ChemAxon
Polarizability25.1 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on October 20, 2016 18:33 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates